Nycomed Amersham:patent property of merging companies.

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.10, 1997-10, pp. : 1069-1074

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patent property of suicide gene therapy involving prodrugs 1996 - 1999

By Springer C.J. Niculescu-Duvaz I.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1381-1388

Informa Healthcare

Access to resources Recommend Favorite

Diabetes area participation analysis: a review of companies and targets described in the 2008 – 2010 patent literature

By Carpino Philip A Goodwin Bryan

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1627-1651

Informa Healthcare

Access to resources Recommend Favorite

Companies in this Issue

Pharmaceutical Innovation, Vol. 12, Iss. 3, 2003-04 ,pp. : 53-54

Adis International

Access to resources Recommend Favorite

Companies in this Issue

Pharmaceutical Innovation, Vol. 12, Iss. 4, 2003-06 ,pp. : 57-58

Adis International

Access to resources Recommend Favorite

Companies in this Issue...

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 3, 2004-06 ,pp. : 60-61

Adis International

Access to resources Recommend Favorite